Fortis Healthcare Limited — Important, 20-12-2024: General Updates

Fortis Healthcare Limited has acquired 5,970,149 equity shares, representing a 7.61% stake in Agilus Diagnostics Limited from the International Finance Corporation (IFC) for INR 429.37 Cr, at a price of INR 719.2 per share. This acquisition is part of a larger composite transaction where Fortis aims to secure a total of 31.52% shareholding in Agilus, which provides comprehensive diagnostics services in India with a strong presence of 407 labs and extensive customer reach.

Agilus generated standalone revenue of INR 85,880.88 Cr and consolidated revenue of INR 137,204.07 Cr for FY 2023-24. The acquisition aligns with Fortis' strategy to enhance its portfolio in the diagnostics space. Industry analysts should monitor this development closely, as it strengthens Fortis's competitive position and growth potential in the healthcare sector.